Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
The Relevance, Predictability, and Utility of Annexin A5 for Human Physiopathology.
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
- المؤلفون: Jing J;Jing J
- المصدر:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 01; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 01.
- نوع النشر :
Journal Article; Review
- اللغة:
English
- معلومة اضافية
- المصدر:
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
- بيانات النشر:
Original Publication: Basel, Switzerland : MDPI, [2000-
- الموضوع:
- نبذة مختصرة :
As an important functional protein molecule in the human body, human annexin A5 (hAnxA5) is widely found in human cells and body fluids. hAnxA5, the smallest type of annexin, performs a variety of biological functions by reversibly and specifically binding phosphatidylserine (PS) in a calcium-dependent manner and plays an important role in many human physiological and pathological processes. The free state hAnxA5 exists in the form of monomers and usually forms a polymer in a specific self-assembly manner when exerting biological activity. This review systematically discusses the current knowledge and understanding of hAnxA5 from three perspectives: physiopathological relevance, diagnostic value, and therapeutic utility. h AnxA5 affects the occurrence and development of many physiopathological processes. Moreover, hAnxA5 can be used independently or in combination as a biomarker of physiopathological phenomena for the diagnosis of certain diseases. Importantly, based on the properties of hAnxA5, many novel drug candidates have been designed and prepared for application in actual medical practice. However, there are also some gaps and shortcomings in h AnxA5 research. This in-depth study will not only expand the understanding of structural and functional relationships but also promote the application of hAnxA5 in the field of biomedicine.
- References:
J Immunol Res. 2015;2015:951424. (PMID: 26075289)
Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):95-101. (PMID: 20947818)
J Cell Mol Med. 2014 Oct;18(10):2117-24. (PMID: 25214012)
Clin Lab. 2002;48(9-10):517-23. (PMID: 12389712)
Atherosclerosis. 2012 Apr;221(2):333-40. (PMID: 22341596)
EMBO J. 1990 Dec;9(12):3867-74. (PMID: 2147412)
J Nucl Med. 2007 Aug;48(8):1301-7. (PMID: 17631551)
Proc Natl Acad Sci U S A. 1987 Sep;84(17):6078-82. (PMID: 2957692)
J Biol Chem. 1992 Sep 5;267(25):17907-12. (PMID: 1387643)
Gene. 1994 Nov 18;149(2):253-60. (PMID: 7958998)
Eur Heart J. 2007 Nov;28(22):2785-91. (PMID: 17766279)
Blood. 2020 Jul 9;136(2):247-256. (PMID: 32285120)
J Biol Chem. 2004 Dec 10;279(50):52623-9. (PMID: 15381697)
Arch Gynecol. 1979 Aug;227(2):125-34. (PMID: 485220)
Biochem Biophys Res Commun. 2009 Dec 4;390(1):161-4. (PMID: 19799864)
Thromb Haemost. 2007 Mar;97(3):478-86. (PMID: 17334517)
Lupus. 2010 Apr;19(4):460-9. (PMID: 20353989)
Cell Death Differ. 2001 Apr;8(4):324-6. (PMID: 11550083)
Tumour Biol. 2014 Dec;35(12):12327-37. (PMID: 25245332)
Allergol Immunopathol (Madr). 2015 Nov-Dec;43(6):538-42. (PMID: 25796304)
Sci Rep. 2020 Jun 10;10(1):9391. (PMID: 32523019)
J Clin Gastroenterol. 2009 Oct;43(9):831-7. (PMID: 19461527)
Prostaglandins Other Lipid Mediat. 2013 Oct;106:72-8. (PMID: 23391726)
Peptides. 2002 Jul;23(7):1249-63. (PMID: 12128082)
Cancer Biomark. 2018;23(1):23-32. (PMID: 30010106)
J Biol Chem. 2004 Oct 15;279(42):43411-8. (PMID: 15302870)
Biochemistry. 1998 Jun 2;37(22):8004-10. (PMID: 9609693)
Circ Res. 1995 Dec;77(6):1136-42. (PMID: 7586226)
Nat Commun. 2020 Feb 28;11(1):1137. (PMID: 32111835)
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. (PMID: 28930295)
Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8054-9. (PMID: 12060752)
Cell Death Differ. 2000 Oct;7(10):911-5. (PMID: 11279536)
Biomacromolecules. 2017 Mar 13;18(3):865-876. (PMID: 28240872)
Oncogene. 2000 Jun 8;19(25):2904-12. (PMID: 10871841)
Nucl Med Biol. 2005 May;32(4):395-402. (PMID: 15878509)
BMC Cancer. 2006 Jun 16;6:159. (PMID: 16780590)
J Mol Biol. 1991 Jan 20;217(2):241-5. (PMID: 1825119)
J Immunotoxicol. 2009 Dec;6(4):209-16. (PMID: 19908939)
J Struct Biol. 2020 Jan 1;209(1):107401. (PMID: 31605770)
Autoimmun Rev. 2003 Mar;2(2):86-93. (PMID: 12848964)
Science. 1993 Sep 3;261(5126):1321-4. (PMID: 8362244)
J Biol Chem. 1989 May 15;264(14):7944-9. (PMID: 2524476)
J Cell Sci. 2003 Jun 15;116(Pt 12):2399-408. (PMID: 12724354)
Am Heart J. 2006 Nov;152(5):828-34. (PMID: 17070141)
Nature. 2000 Oct 12;407(6805):770-6. (PMID: 11048727)
Biochemistry. 1987 Aug 25;26(17):5572-8. (PMID: 2960376)
Biol Chem. 1997 Mar-Apr;378(3-4):177-83. (PMID: 9165068)
Genomics. 1994 Apr;20(3):463-7. (PMID: 8034319)
Nihon Sanka Fujinka Gakkai Zasshi. 1986 Feb;38(2):265-6. (PMID: 2937860)
Int Rev Immunol. 2013 Apr;32(2):134-56. (PMID: 23570314)
Clin Chim Acta. 1996 Jul 15;251(1):65-80. (PMID: 8814351)
Lupus. 2008 Oct;17(10):922-30. (PMID: 18827057)
Thromb Res. 2018 May 17;167:104-112. (PMID: 29803980)
Front Aging Neurosci. 2013 Apr 05;5:15. (PMID: 23576984)
J Proteomics. 2012 Apr 18;75(8):2352-60. (PMID: 22348822)
J Biol Chem. 1995 Sep 15;270(37):21594-9. (PMID: 7665573)
J Clin Med. 2022 Jan 28;11(3):. (PMID: 35160128)
PLoS One. 2021 Feb 22;16(2):e0246806. (PMID: 33617530)
Sci Rep. 2020 Mar 4;10(1):4057. (PMID: 32132597)
Int J Rheum Dis. 2013 Jun;16(3):325-30. (PMID: 23981755)
J Immunol. 2010 Jul 1;185(1):605-14. (PMID: 20498354)
Biochim Biophys Acta. 1994 Apr 5;1197(1):63-93. (PMID: 8155692)
Nihon Sanka Fujinka Gakkai Zasshi. 1989 Oct;41(10):1537-44. (PMID: 2531190)
Biochem J. 1994 Aug 15;302 ( Pt 1):305-12. (PMID: 8068019)
Crit Care Med. 2014 Jan;42(1):e32-41. (PMID: 24145837)
J Lab Clin Med. 1990 Feb;115(2):174-81. (PMID: 2137157)
Appl Radiat Isot. 2008 Sep;66(9):1175-82. (PMID: 18308577)
Blood. 2006 Feb 1;107(3):980-6. (PMID: 16195337)
Prog Lipid Res. 2003 Sep;42(5):423-38. (PMID: 12814644)
Nat Med. 1995 Feb;1(2):149-53. (PMID: 7585012)
Zhonghua Yi Xue Za Zhi. 2007 Aug 14;87(30):2094-7. (PMID: 17988525)
Biochemistry. 2009 Nov 10;48(44):10568-76. (PMID: 19810772)
FEBS Lett. 2001 Mar 30;493(2-3):122-8. (PMID: 11287008)
J Immunol Methods. 2002 Jul 1;265(1-2):123-32. (PMID: 12072183)
Biochim Biophys Acta. 2008 Jun;1783(6):953-63. (PMID: 18334229)
Adv Clin Exp Med. 2020 May;29(5):603-609. (PMID: 32469166)
Int J Mol Sci. 2013 Jan 28;14(2):2652-83. (PMID: 23358253)
J Biol Chem. 2019 Apr 26;294(17):6670-6684. (PMID: 30803987)
J Biol Chem. 1990 Mar 25;265(9):4923-8. (PMID: 2138622)
Nihon Rinsho. 1989 Apr;47(4):844-50. (PMID: 2526262)
Nucl Med Biol. 2011 Apr;38(3):381-92. (PMID: 21492787)
J Immunol. 2015 Jun 1;194(11):5233-42. (PMID: 25917090)
Phytother Res. 2012 May;26(5):646-56. (PMID: 22517511)
Science. 1993 Oct 15;262(5132):427-30. (PMID: 7692599)
Thromb Haemost. 2004 Jun;91(6):1129-36. (PMID: 15175799)
Proc Natl Acad Sci U S A. 1988 Jun;85(11):3708-12. (PMID: 2967495)
Int J Oncol. 2017 May;50(5):1839-1847. (PMID: 28393205)
Endocrinology. 2003 Apr;144(4):1164-74. (PMID: 12639897)
Blood Coagul Fibrinolysis. 1992 Feb;3(1):11-7. (PMID: 1623112)
Lung. 2018 Dec;196(6):681-689. (PMID: 30182154)
Br J Haematol. 2022 Mar;196(5):1159-1169. (PMID: 34962643)
FEBS Lett. 1992 Dec 14;314(2):159-62. (PMID: 1459245)
Redox Biol. 2020 Sep;36:101634. (PMID: 32863213)
Biomaterials. 2019 Apr;198:63-77. (PMID: 30098794)
J Struct Biol. 2000 Sep;131(3):234-9. (PMID: 11052896)
Nat Biomed Eng. 2020 Nov;4(11):1102-1116. (PMID: 32807941)
J Biol Chem. 2005 Feb 18;280(7):6028-35. (PMID: 15576370)
Am Rev Respir Dis. 1987 May;135(5):1043-8. (PMID: 2437839)
Am J Obstet Gynecol. 1997 Oct;177(4):964-72. (PMID: 9369853)
Cancer Biother Radiopharm. 2001 Feb;16(1):73-83. (PMID: 11279800)
Nature. 2000 Oct 12;407(6805):784-8. (PMID: 11048729)
Regul Pept. 1998 Feb 2;73(2):133-9. (PMID: 9533818)
J Intern Med. 2016 Jan;279(1):89-97. (PMID: 26223343)
Toxicol Ind Health. 2016 Sep;32(9):1628-38. (PMID: 25757482)
Theranostics. 2020 Jul 23;10(20):9214-9229. (PMID: 32802188)
Biochemistry. 1996 Jan 23;35(3):922-9. (PMID: 8547274)
Biochem Biophys Res Commun. 2003 Jul 11;306(4):1026-36. (PMID: 12821146)
J Mol Biol. 1994 Apr 29;238(2):199-213. (PMID: 8158649)
J Cell Biol. 1984 Apr;98(4):1572-9. (PMID: 6325473)
Nat Struct Biol. 1995 Nov;2(11):968-74. (PMID: 7583670)
Lupus. 2013 Jun;22(7):702-11. (PMID: 23690366)
Biochem J. 1993 Apr 15;291 ( Pt 2):595-600. (PMID: 8484739)
Cell Biol Int. 2020 Feb;44(2):391-401. (PMID: 31502716)
J Struct Biol. 2001 Jan;133(1):55-63. (PMID: 11356064)
Eur J Biochem. 1982 Feb;122(2):429-36. (PMID: 7060583)
Immunobiology. 2005;210(10):761-8. (PMID: 16325495)
Cell Mol Life Sci. 1997 Jun;53(6):516-21. (PMID: 9230929)
Cell Death Dis. 2018 May 25;9(6):637. (PMID: 29802377)
Eur J Biochem. 1992 Nov 15;210(1):73-7. (PMID: 1446685)
J Biol Chem. 1988 Aug 5;263(22):10799-811. (PMID: 2968983)
Best Pract Res Clin Rheumatol. 2016 Feb;30(1):133-48. (PMID: 27421221)
Cell Rep. 2019 Dec 24;29(13):4435-4446.e9. (PMID: 31875551)
Am J Obstet Gynecol. 2011 Dec;205(6):576.e7-14. (PMID: 21871597)
Eur J Endocrinol. 2012 Apr;166(4):657-67. (PMID: 22275472)
Endocrinology. 2006 Jul;147(7):3219-27. (PMID: 16601136)
Bioconjug Chem. 2004 Mar-Apr;15(2):373-9. (PMID: 15025534)
J Nucl Med. 2010 Feb;51(2):259-67. (PMID: 20124049)
J Neurosci Res. 2010 Sep;88(12):2682-92. (PMID: 20648654)
Physiol Rev. 2002 Apr;82(2):331-71. (PMID: 11917092)
- Grant Information:
No. BNU110107977 Beijing Nomal University
- Contributed Indexing:
Keywords: human annexin A5; phosphatidylserine (PS); physiopathology; self-assembly
- الرقم المعرف:
0 (Annexin A5)
SY7Q814VUP (Calcium)
0 (Calcium, Dietary)
0 (Phosphatidylserines)
0 (ANXA5 protein, human)
- الموضوع:
Date Created: 20240313 Date Completed: 20240314 Latest Revision: 20240319
- الموضوع:
20250114
- الرقم المعرف:
PMC10932194
- الرقم المعرف:
10.3390/ijms25052865
- الرقم المعرف:
38474114
No Comments.